Kellner Capital’s Array Biopharma Inc ARRY Stock Holding History

Kellner Capital’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-82,900	Closed	-$3.84M	–	37
2019 Q2	$3.84M	Buy	+82,900	New	+$2.33M	1.72%	19

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Kellner Capital's ARRY Position: Q3 2019 in Review

Kellner Capital sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 82,900 shares — an estimated $3.84M sold.

Kellner Capital first reported a position in ARRY in Q2 2019 and held it in 1 quarter. The position peaked at $3.84M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Kellner Capital reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Kellner Capital sold 82,900 Array Biopharma Inc shares in Q3 2019, an estimated $3.84M.
Kellner Capital first reported a position in Array Biopharma Inc in Q2 2019 and held it in 1 quarter.
Kellner Capital's Array Biopharma Inc position peaked at $3.84M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Kellner Capital's 13F filing for Q3 2019, filed 14 Nov 2019.